933988-20-6 Usage
Uses
Used in Pharmaceutical Industry:
2-pyridin-3-ylpyrimidine-5-carboxylic acid serves as a key building block for the synthesis of various biologically active molecules. It is utilized in drug discovery and development due to its capacity to interact with biological targets and modulate specific biochemical pathways, contributing to the creation of novel therapeutic agents.
Used as a Research Tool in Chemical and Biological Studies:
In the realm of scientific research, 2-pyridin-3-ylpyrimidine-5-carboxylic acid is employed to explore its potential applications in medicine and drug design. Its unique structure and properties make it a valuable asset for investigating new approaches to treating diseases and improving healthcare outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 933988-20-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,3,9,8 and 8 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 933988-20:
(8*9)+(7*3)+(6*3)+(5*9)+(4*8)+(3*8)+(2*2)+(1*0)=216
216 % 10 = 6
So 933988-20-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H7N3O2/c14-10(15)8-5-12-9(13-6-8)7-2-1-3-11-4-7/h1-6H,(H,14,15)
933988-20-6Relevant articles and documents
PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS
-
Page/Page column 55, (2008/12/04)
This invention is directed to a compound wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or
PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS
-
Page/Page column 36, (2010/11/26)
This invention is directed to a compound of formula (I): wherein R1, R2, R3 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
